Autophagy inhibition sensitizes LY3023414-induced anti-glioma cell activity in vitro and in vivo

PI3K-AKT-mTOR signaling is a valuable treatment target for human glioma. LY3023414 is a novel, highly-potent and pan PI3K-AKT-mTOR inhibitor. Here, we show that LY3023414 efficiently inhibited survival and proliferation of primary and established human glioma cells. Meanwhile, apoptosis activation w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lan, Li, Huanyin, Mo, Yanqing, Qi, Gong, Liu, Bin, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716781/
https://www.ncbi.nlm.nih.gov/pubmed/29228741
http://dx.doi.org/10.18632/oncotarget.22147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716781/
https://www.ncbi.nlm.nih.gov/pubmed/29228741
http://dx.doi.org/10.18632/oncotarget.22147

Ejemplares similares